ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kimikazu Hamano
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamano, K.
Right arrow Articles by Matsuzaki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamano, K.
Right arrow Articles by Matsuzaki, M.
Related Collections
Right arrow Molecular biology

Ann Thorac Surg 2002;73:1210-1215
© 2002 The Society of Thoracic Surgeons

Original article: cardiovascular

Therapeutic angiogenesis induced by local autologous bone marrow cell implantation

Kimikazu Hamano, MD*a, Tao-Sheng Li, MDa, Toshiro Kobayashi, MDa, Ken Hirata, MDa, Masafumi Yano, MDa, Michihiro Kohno, MDa, Masunori Matsuzaki, MDa

a First Department of Surgery and Second Department of Internal Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan

Accepted for publication December 17, 2001.

* Address reprint requests to Dr Hamano, First Department of Surgery, Yamaguchi University School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, Japan 755-8505
e-mail: kimikazu{at}po.cc.yamaguchi-u.ac.jp

Background. Therapeutic angiogenesis was induced by local autologous bone marrow cell implantation (BMCI) in ischemic hindlimb or ischemic heart models in rats. This study was designed to investigate the toxicity and therapeutic potency of local BMCI using a chronic coronary occlusion model in dogs.

Methods. The canine chronic coronary occlusion model was created by ligating of the left anterior descending artery (LAD). The myocardium in the left ventricle was divided into distinct normal, marginal, and infarction areas 30 days after LAD ligation. Each area was injected at two locations, with either 2 x 107 bone marrow cells (n = 7, BMCI group) or 0.1 mL phosphate-buffered saline (PBS) only (n = 7, PBS group), respectively. Hemodynamics were evaluated by a single ultrasonic transducer and echocardiography before and 30 days after the treatment. Angiogenesis was evaluated by vessel count 30 days after the treatment. The toxicity of BMCI treatment was also evaluated in 8 normal dogs by following changes in electrocardiography (ECG), echocardiography, local histology, and systemic biochemistry indexes.

Results. There was a significantly higher percentage of wall thickening in the marginal area in the BMCI group than in the PBS group 30 days after treatment (14.5 ± 2.28 versus 8.1 ± 3.00, p = 0.002). Significantly more microvessels were observed in the marginal area in the BMCI group than in the PBS group 30 days after treatment (127.7 ± 20.1 versus 88.0 ± 10.2/field, p = 0.0007). No systemic or local toxicity was found following BMCI treatment in the acute or chronic phases.

Conclusions. BMCI treatment improved local wall thickening dynamics, presumably due to the angiogenesis induced by the treatment. This indicates that it might be a safe and effective therapy for ischemic heart disease.




This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
E. L. Olivares, R. H. Costa-e-Sousa, J. P.S. Werneck-de-Castro, V. Pinho-Ribeiro, M. G. Silva, K. C. Ribeiro, E. C. Mattos, R. C.S. Goldenberg, A. C. C. de Carvalho, and M. O. Masuda
Cellular cardiomyoplasty in large myocardial infarction: Can the beneficial effect be enhanced by ACE-inhibitor therapy?
Eur J Heart Fail, June 1, 2007; 9(6-7): 558 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Takahashi, T.-S. Li, R. Suzuki, T. Kobayashi, H. Ito, Y. Ikeda, M. Matsuzaki, and K. Hamano
Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H886 - H893.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. A. de Oliveira, L. H. W. Gowdak, G. Buckberg, J. E. Krieger, and the RESTORE Group
Cell biology, MRI and geometry: insight into a microscopic/macroscopic marriage
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S259 - S265.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
L. Ye, H. K. Haider, and E. K. W. Sim
Adult Stem Cells for Cardiac Repair: A Choice Between Skeletal Myoblasts and Bone Marrow Stem Cells
Experimental Biology and Medicine, January 1, 2006; 231(1): 8 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Kanamori, G. Watanabe, T. Yasuda, H. Nagamine, H. Kamiya, and Y. Koshida
Hybrid Surgical Angiogenesis: Omentopexy Can Enhance Myocardial Angiogenesis Induced by Cell Therapy
Ann. Thorac. Surg., January 1, 2006; 81(1): 160 - 167.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. E. Murry, L. J. Field, and P. Menasche
Cell-Based Cardiac Repair: Reflections at the 10-Year Point
Circulation, November 15, 2005; 112(20): 3174 - 3183.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
I. Dimarakis, N. A. Habib, and M. Y.A. Gordon
Adult bone marrow-derived stem cells and the injured heart: just the beginning?
Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 665 - 676.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Haider and M. Ashraf
Bone marrow stem cell transplantation for cardiac repair
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2557 - H2567.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
T. Kinnaird, E. Stabile, M. S. Burnett, and S. E. Epstein
Bone Marrow-Derived Cells for Enhancing Collateral Development: Mechanisms, Animal Data, and Initial Clinical Experiences
Circ. Res., August 20, 2004; 95(4): 354 - 363.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. C. Chachques, F. Duarte, B. Cattadori, A. Shafy, N. Lila, G. Chatellier, J.-N. Fabiani, and A. F. Carpentier
Angiogenic growth factors and/or cellular therapy for myocardial regeneration: A comparative study
J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 245 - 253.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Fujii, S. Tomita, T. Nakatani, S. Fukuhara, A. Hanatani, Y. Ohtsu, M. Ishida, C. Yutani, K. Miyatake, and S. Kitamura
A novel application of myocardial contrast echocardiography to evaluate angiogenesis by autologous bone marrow cell transplantation in chronic ischemic pig model
J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1299 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Bel, E. Messas, O. Agbulut, P. Richard, J. L. Samuel, P. Bruneval, A. A. Hagege, and P. Menasche
Transplantation of Autologous Fresh Bone Marrow Into Infarcted Myocardium: A Word of Caution
Circulation, September 9, 2003; 108(90101): II-247 - 252.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. Menasche
Cell transplantation in myocardium
Ann. Thorac. Surg., June 1, 2003; 75(90060): S20 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. D. Dowell, M. Rubart, K. B.S. Pasumarthi, M. H. Soonpaa, and L. J. Field
Myocyte and myogenic stem cell transplantation in the heart
Cardiovasc Res, May 1, 2003; 58(2): 336 - 350.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.